Chapters
Chapter 1
Introduction, outline and aims of the thesis.
This chapter is a part of the authoritative review 'How we manage patients with hereditary haemochromatosis'.
Br J Haematol 2016 Oct 10 [Epub ahead of print] Review.
Chapter 2
Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis ‐ A pilot study.
Transfus Apher Sci 2007; 36(3):261-7.
Chapter 3
Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial.
Transfusion 2012; 52(3):470-7.
Chapter 4
Course of iron parameters in HFE‐Hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.
J Clin Apher 2016 Feb 16.
Chapter 5
Predicting the number of treatments in naïve hereditary hemochromatosis patients treated by phlebotomy or erythrocytapheresis.
Chapter 6
Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients; results from a randomized cross‐over trial.
Transfusion 2016; 56(1):261-70.
Chapter 7
End‐stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.
Circ Heart Fail 2014; 7(3):541-3.
https://www.ncbi.nlm.nih.gov/pubmed/24847131
Chapter 8
General discussion and summary
